Tag: Parliamentary Question

  • Cat Smith – 2016 Parliamentary Question to the Department for Work and Pensions

    Cat Smith – 2016 Parliamentary Question to the Department for Work and Pensions

    The below Parliamentary question was asked by Cat Smith on 2016-03-16.

    To ask the Secretary of State for Work and Pensions, if he will make an assessment of the role of personal independence payment assessment providers in the increase in processing time between the case referral to assessment provider to return from the assessment provider to the government office since July 2015.

    Justin Tomlinson

    Following a controlled start from July 2015, full Personal Independence Payment (PIP) roll-out commenced in October 2015, with an increase in the numbers of existing Disability Living Allowance claimants being asked to claim PIP.

    In addition and in order to improve the customer journey, the Department has made some changes to the way in which it monitors Assessment Provider performance. These changes mean that Providers now have more time in which to complete assessments and return reports to the Department and also gives them greater flexibility to obtain further evidence to support claims: this therefore allows more time for scheduling appointments that better suit claimants and Assessment Providers, increases accuracy in assessments and reports and ensures opportunities for paper based reviews are maximised thereby reducing the demand for face-to-face appointments. Although these changes may see slightly longer average clearance times, they remain within expected levels.

  • Steve McCabe – 2016 Parliamentary Question to the Home Office

    Steve McCabe – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Steve McCabe on 2016-04-14.

    To ask the Secretary of State for the Home Department, pursuant to the Answer of 12 April 2016 to Question 32506, what proportion of asylum claims made by unaccompanied children of refugees who had already been granted asylum in the UK were granted in each of the last three years.

    James Brokenshire

    I refer the Rt. Hon. Member to the answer I gave on 15 March 2015 to his question 30647. The Home Office publishes quarterly figures on asylum claims from Unaccompanied Asylum Seeking Children (UASC) in the Immigration Statistics release. This includes information on applications received, decisions made by sex, age and country of nationality.

  • Stephen Timms – 2016 Parliamentary Question to the Ministry of Defence

    Stephen Timms – 2016 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by Stephen Timms on 2016-05-23.

    To ask the Secretary of State for Defence, what opportunities the Department offers to trainee soldiers under the age of 18 to re-sit GCSEs as part of their elective personal development.

    Mark Lancaster

    I refer the hon. Member to the answer I gave on 23 May to Question number 37109.

  • Alan Meale – 2016 Parliamentary Question to the Department for Business, Energy and Industrial Strategy

    Alan Meale – 2016 Parliamentary Question to the Department for Business, Energy and Industrial Strategy

    The below Parliamentary question was asked by Alan Meale on 2016-07-19.

    To ask the Secretary of State for Business, Energy and Industrial Strategy, which signatories to the Coal Workers Pneumoconiosis Scheme 1974 were consulted by his Department prior to the inclusion in the tender document to administer that scheme a requirement that all claims to that scheme be accompanied by a grant of probate.

    Jesse Norman

    There was no separate tender document for the administration of the Coal Workers Pneumoconiosis Scheme (CWPS), hence there was no such consultation.

  • Paul Flynn – 2016 Parliamentary Question to the Wales Office

    Paul Flynn – 2016 Parliamentary Question to the Wales Office

    The below Parliamentary question was asked by Paul Flynn on 2016-10-07.

    To ask the Secretary of State for Wales, what estimate he has made of the net benefit to the Welsh economy of jobs created as a result of the construction of Hinkley Point C nuclear power plant.

    Alun Cairns

    The UK Government does not hold the specific figures requested. The decision to proceed with the first new nuclear power station for a generation will provide a huge boost to the regional economy including South Wales. Construction at the Hinkley site will provide 26,000 jobs and apprenticeships, and 64% of the project’s costs will be spent in the UK.

    Welsh companies are already taking advantage of the opportunities this project presents, for example, Express Reinforcements in South Wales was given preferred bidder status for a £100m contract to supply 200,000 tonnes of reinforcing steel for the project.

    I would encourage businesses in Wales to register with EDF in order to take advantage of upcoming supply chain opportunities.

  • William Cash – 2015 Parliamentary Question to the Department for International Development

    William Cash – 2015 Parliamentary Question to the Department for International Development

    The below Parliamentary question was asked by William Cash on 2015-11-19.

    To ask the Secretary of State for International Development, whether (a) she or (b) another Minister from her Department plans to attend the Nutrition for Growth Summit schedules to take place during the Rio Summer Olympics.

    Grant Shapps

    We have yet to receive a formal invitation to the Nutrition for Growth Summit from the Government of Brazil. Once an invitation is received a decision will be taken on ministerial attendance.

    DFID are working closely with the Brazilian government to support them in their preparations for the summit.

  • Diana Johnson – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    Diana Johnson – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    The below Parliamentary question was asked by Diana Johnson on 2015-12-17.

    To ask the Secretary of State for Culture, Media and Sport, when he plans to publish the responses to his Department’s consultation on the future of the BBC.

    Mr Edward Vaizey

    The Government’s BBC Charter Review Public Consultation closed in October. Over 190,000 people responded to the consultation – the second largest response to any Government consultation. We are in the process of reading and analysing all the responses, and will publish the results once this exercise is completed.

  • Lord Mawhinney – 2016 Parliamentary Question to the Department of Health

    Lord Mawhinney – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mawhinney on 2016-01-27.

    To ask Her Majesty’s Government what is their estimate of how many people in the UK have Lyme disease.

    Lord Prior of Brampton

    It is not practical to eradicate Lyme disease in the United Kingdom through treatment of human cases, therefore no cost estimate has been made. The disease is endemic in much of the small mammal and bird population in the UK, and is spread to humans by the bite of infected ticks which have fed on these animals. The number of human cases can be reduced by raising public awareness of how to avoid tick bites, and by environmental measures in public places to reduce the long grass and scrub which harbour ticks.

    The number of laboratory confirmed cases of Lyme disease in England and Wales varies annually, in 2013 there were 878 and in 2014 there were 730, but the majority of diagnoses are made clinically by general practitioners and those figures are not recorded. Patients with late or complicated Lyme disease may be diagnosed in a variety of specialist clinics, and the numbers are not recorded. Based on the clinical information supplied with the laboratory request, only a small proportion of the annual number of cases fall into this category.

    The Health Protection Research Unit of the University of Liverpool in partnership with Public Health England (PHE) has funding from the National Institute of Health Research for research into Lyme disease, covering diagnostics and biomarkers and public awareness. PHE is working on clinically linked studies for diagnostics with the Czech Republic, as no single centre in the UK has sufficient patients for a suitable study; funding for this work is not yet in place. PHE undertakes limited studies on ticks and Lyme disease in the UK. The Research Councils fund some additional work on ticks and the environment.

  • Valerie Vaz – 2016 Parliamentary Question to the Department for Work and Pensions

    Valerie Vaz – 2016 Parliamentary Question to the Department for Work and Pensions

    The below Parliamentary question was asked by Valerie Vaz on 2016-02-22.

    To ask the Secretary of State for Work and Pensions, how many people with epilepsy are claiming employment and support allowance and personal independence payments.

    Priti Patel

    The number of Employment and Support Allowance claimants with epilepsy as their main disabling condition, as at August 2015, is 44,720.

    Information on the number of people in receipt of Personal Independence Payment at 31 October 2015, by a range of conditions including epilepsy, has been published and can be found at:

    https://stat-xplore.dwp.gov.uk.

    Guidance on how to extract the information required can be found at:

    https://sw.stat-xplore.dwp.gov.uk/webapi/online-help/Getting-Started—SuperWEB2.html

    “

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-03-16.

    To ask Her Majesty’s Government whether people continue to have the right to drugs and treatments that have been recommended by NICE technology appraisals for use in the NHS if their doctor says they are clinically appropriate.

    Lord Prior of Brampton

    Yes. The NHS Constitution for England affirms, “You have the right to drugs and treatments that have been recommended by the National Institute for Health and Care Excellence for use in the NHS, if your doctor says they are clinically appropriate for you”.